Cross-sectional investigation of mycological diagnosis challenges in Saudi Arabia.
Aspergillus
Candida
Saudi Arabia
antifungal
diagnosis
mycology
resistance
susceptibility
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2023
2023
Historique:
received:
11
04
2023
accepted:
19
05
2023
medline:
13
7
2023
pubmed:
12
7
2023
entrez:
12
7
2023
Statut:
epublish
Résumé
The global incidence of fungal infection has increased dramatically over the last two decades. Fungal diseases threaten both immunocompetent, and immunocompromised patients. The current fungal diagnostics status in Saudi Arabia needs to be evaluated, especially with the increase of the immunosuppressed population. This cross-sectional study investigated the gaps in mycological diagnosis on a national level. The call interview questionnaire responses were collected to evaluate the demand for fungal assays, diagnostic methods' quality, and mycological expertise of laboratory technologists in both public and private medical intuitions. The data were analyzed using (IBM SPSS A total of 57 hospitals from all Saudi regions participated in the questionnaire; however, only 32% received or processed mycological samples. Most participants were from the Mecca region (25%), Riyadh region (19%), and Eastern region (14%). The top fungal isolates identified were The results indicated that fungal diagnosis demand was relatively higher in high-population regions. This study highlighted the gaps in fungal diagnostics reference laboratories to encourage their improvement in Saudi hospitals.
Sections du résumé
Background
The global incidence of fungal infection has increased dramatically over the last two decades. Fungal diseases threaten both immunocompetent, and immunocompromised patients. The current fungal diagnostics status in Saudi Arabia needs to be evaluated, especially with the increase of the immunosuppressed population. This cross-sectional study investigated the gaps in mycological diagnosis on a national level.
Materials and methods
The call interview questionnaire responses were collected to evaluate the demand for fungal assays, diagnostic methods' quality, and mycological expertise of laboratory technologists in both public and private medical intuitions. The data were analyzed using (IBM SPSS
Results
A total of 57 hospitals from all Saudi regions participated in the questionnaire; however, only 32% received or processed mycological samples. Most participants were from the Mecca region (25%), Riyadh region (19%), and Eastern region (14%). The top fungal isolates identified were
Conclusions
The results indicated that fungal diagnosis demand was relatively higher in high-population regions. This study highlighted the gaps in fungal diagnostics reference laboratories to encourage their improvement in Saudi hospitals.
Identifiants
pubmed: 37434785
doi: 10.3389/fcimb.2023.1203892
pmc: PMC10332264
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1203892Informations de copyright
Copyright © 2023 Khateb and Alkhaibari.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Ann Clin Lab Sci. 2019 Sep;49(4):546-549
pubmed: 31471347
Mycoses. 1991 Jul-Aug;34(7-8):339-44
pubmed: 1803239
Lancet Microbe. 2022 Jun;3(6):e464-e470
pubmed: 35659908
Eur J Med Res. 2020 Jan 4;25(1):1
pubmed: 31901238
Scientifica (Cairo). 2013;2013:459405
pubmed: 24278780
Med Mycol. 2018 Jun 1;56(4):416-425
pubmed: 29036605
J Clin Microbiol. 2015 Jun;53(6):1823-30
pubmed: 25809970
Infect Control Hosp Epidemiol. 2021 Feb;42(2):149-155
pubmed: 32880247
F1000Res. 2017 Feb 17;6:
pubmed: 28299183
J Thorac Imaging. 2006 Aug;21(3):184-9
pubmed: 16915062
J Fungi (Basel). 2017 Oct 18;3(4):
pubmed: 29371573
ACG Case Rep J. 2021 May 14;8(5):e00573
pubmed: 34007854
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Infect Control Hosp Epidemiol. 2021 Nov;42(11):1301-1306
pubmed: 33557978
Saudi Med J. 2014 Aug;35(8):821-6
pubmed: 25129180
J Microbiol Immunol Infect. 2020 Dec;53(6):845-853
pubmed: 32334978
J Epidemiol Glob Health. 2021 Dec;11(4):405-412
pubmed: 34734382
Int J Vet Sci Med. 2020 Dec 17;8(1):115-123
pubmed: 33426048
J Clin Microbiol. 2020 Mar 25;58(4):
pubmed: 31996441
BMC Infect Dis. 2020 Jan 17;20(1):55
pubmed: 31952505
Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5
pubmed: 16127033
Front Genet. 2020 Apr 15;11:351
pubmed: 32351544
J Formos Med Assoc. 2018 Jun;117(6):462-470
pubmed: 29122404
J Fungi (Basel). 2019 Aug 20;5(3):
pubmed: 31434222